Algert Global LLC lifted its position in shares of LiveRamp Holdings, Inc. (NYSE:RAMP - Free Report) by 107.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 218,906 shares of the company's stock after buying an additional 113,161 shares during the period. Algert Global LLC owned approximately 0.34% of LiveRamp worth $5,424,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in RAMP. DT Investment Partners LLC purchased a new stake in LiveRamp during the second quarter worth approximately $27,000. Quarry LP boosted its position in LiveRamp by 4,575.0% during the 2nd quarter. Quarry LP now owns 935 shares of the company's stock worth $29,000 after purchasing an additional 915 shares during the period. Blue Trust Inc. increased its holdings in LiveRamp by 187.1% in the 2nd quarter. Blue Trust Inc. now owns 1,065 shares of the company's stock valued at $33,000 after purchasing an additional 694 shares in the last quarter. DekaBank Deutsche Girozentrale purchased a new position in LiveRamp in the first quarter valued at about $87,000. Finally, Quest Partners LLC lifted its stake in shares of LiveRamp by 68.8% during the second quarter. Quest Partners LLC now owns 2,998 shares of the company's stock worth $93,000 after purchasing an additional 1,222 shares in the last quarter. Institutional investors and hedge funds own 93.83% of the company's stock.
Analysts Set New Price Targets
RAMP has been the topic of a number of recent analyst reports. Macquarie reiterated an "outperform" rating and issued a $43.00 price objective on shares of LiveRamp in a report on Thursday, November 7th. Benchmark lowered their price objective on LiveRamp from $48.00 to $42.00 and set a "buy" rating for the company in a research note on Thursday, November 7th. Craig Hallum dropped their price objective on LiveRamp from $55.00 to $43.00 and set a "buy" rating on the stock in a report on Thursday, August 8th. Wells Fargo & Company began coverage on shares of LiveRamp in a research report on Monday, October 28th. They set an "equal weight" rating and a $25.00 price target for the company. Finally, Evercore ISI dropped their price target on shares of LiveRamp from $50.00 to $40.00 and set an "outperform" rating for the company in a research note on Thursday, August 8th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, LiveRamp has a consensus rating of "Moderate Buy" and a consensus target price of $41.14.
View Our Latest Research Report on LiveRamp
Insider Activity at LiveRamp
In other news, Director Debora B. Tomlin sold 9,765 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $25.07, for a total value of $244,808.55. Following the completion of the sale, the director now owns 24,509 shares in the company, valued at $614,440.63. This represents a 28.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CTO Mohsin Hussain sold 5,773 shares of LiveRamp stock in a transaction on Friday, August 30th. The shares were sold at an average price of $25.98, for a total value of $149,982.54. Following the transaction, the chief technology officer now owns 73,614 shares in the company, valued at $1,912,491.72. This represents a 7.27 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 19,538 shares of company stock worth $495,471 in the last quarter. 3.39% of the stock is owned by company insiders.
LiveRamp Trading Up 0.8 %
NYSE:RAMP traded up $0.24 during midday trading on Monday, hitting $30.95. 1,035,508 shares of the stock were exchanged, compared to its average volume of 646,441. The business has a 50-day moving average price of $25.91 and a two-hundred day moving average price of $27.96. The company has a market capitalization of $2.02 billion, a price-to-earnings ratio of 619.12 and a beta of 0.96. LiveRamp Holdings, Inc. has a one year low of $21.45 and a one year high of $42.66.
LiveRamp (NYSE:RAMP - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.37 by $0.14. The firm had revenue of $185.00 million for the quarter, compared to analysts' expectations of $176.16 million. LiveRamp had a net margin of 0.40% and a return on equity of 1.25%. LiveRamp's revenue for the quarter was up 15.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.21 earnings per share. Sell-side analysts forecast that LiveRamp Holdings, Inc. will post 0.36 EPS for the current fiscal year.
LiveRamp Company Profile
(
Free Report)
LiveRamp Holdings, Inc, a technology company, operates a data collaboration platform in the United States, Europe, the Asia-Pacific, and internationally. The company operates LiveRamp Data Collaboration platform enables an organization to unify customer and prospect data to build a single view of the customer in a way that protects consumer privacy.
Recommended Stories
Before you consider LiveRamp, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LiveRamp wasn't on the list.
While LiveRamp currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.